Get started
Author

Eduardo Bruno Martins

Observed names: E B Martins, E Martins, E. B Martins, E. B. Martins, E. Martins, E.B. Martins, EDUARDO B. MARTINS, Eduardo B. Martins, Eduardo B.G. Martins, Eduardo Bruno MartinsⅡ, Eduardo Martins, Martins, Eduardo Bruno
Observed institutions: Universidade Federal do Rio de Janeiro, Universidade de São Paulo, Genentech, Yonsei University, Severance Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Princess Royal Hospital, John Radcliffe Hospital, Dynavax Technologies (United States), Pusan National University Hospital, SciClone Pharmaceuticals (United States), Chi Mei Medical Center, Allergan (United States), Gilead Sciences (United States), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, CHA University, Azienda Ospedaliera Fatebenefratelli e Oftalmico, Johnson & Johnson (Brazil), Yonsei University Health System, Instituto do Coração - HCFMUSP, Sagimet Biosciences Inc. (United States), Pusan National University, University of the Philippines Manila
ORCID: 0000-0003-1947-7784
Observed ORCID: 0000-0003-1947-7784
OpenAlex ID: A5064594473
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
2015 · Patrick Marcellin, Sang Hoon Ahn, et al. · Gastroenterology · 342
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
2014 · Maria Buti, Naoky Tsai, et al. · Digestive Diseases and Sciences · 298
PDF
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
2015 · W. Ray Kim, Thomas Berg, et al. · Journal of Hepatology · 297
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
2015 · W. Ray Kim, Rohit Loomba, et al. · Cancer · 212
PDF
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
2012 · Scott A. Halperin, Brian Ward, et al. · Vaccine · 130
Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load
2013 · Stuart C. Gordon, Zahary Krastev, et al. · Hepatology · 116
PDF
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
2024 · Rohit Loomba, Pierre Bedossa, et al. · ˜The œLancet. Gastroenterology & hepatology · 114
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models
2022 · Marie O’Farrell, Greg Duke, et al. · Scientific Reports · 105
PDF
Elevation of γδ T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases
1996 · E B Martins, A K Graham, et al. · Hepatology · 98
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B
2015 · Henry Lik-Yuen Chan, Magdy Elkhashab, et al. · Journal of Hepatology · 64
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
2015 · Maria Buti, Scott Fung, et al. · Hepatology International · 60
PDF
The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial
2005 · S. Iino, J. Toyota, et al. · Journal of Viral Hepatitis · 58
Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases
1996 · E Martins · Hepatology · 55
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
2020 · Bertus Eksteen, Christopher L. Bowlus, et al. · Hepatology Communications · 51
Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis
1994 · Eduardo B.G. Martins, Kenneth A. Fleming, et al. · Gastroenterology · 49
PDF
In vitro effect of thymosin‐α1 and interferon‐α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
2001 · P. Andreone, C. Cursaro, et al. · Journal of Viral Hepatitis · 46
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B
2016 · P. Marcellin, S. H. Ahn, et al. · Alimentary Pharmacology & Therapeutics · 44
43 Long Term Tenofovir Disoproxil Fumarate (tdf) Therapy and the Risk of Hepatocellular Carcinoma
2013 · W.R. Kim, T. Berg, et al. · Journal of Hepatology · 37
Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials
2015 · Tram T. Tran, Stuart C. Gordon, et al. · PLoS ONE · 25
PDF
Hepatitis B Screening and Vaccination Practices in Asian American Primary Care
2013 · Danny Chu, Ju Dong Yang, et al. · Gut and Liver · 25
An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology
2023 · Carson McNeil, Pok Fai Wong, et al. · Modern Pathology · 22
PDF
Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases.
1996 · E B Martins, R W Chapman, et al. · Journal of Clinical Pathology · 15
PDF
Safety and Efficacy of the Novel Vaccine TOLAMBA™ in Ragweed Allergic Adults, a Dose Finding Study
2007 · D.I. Bernstein, N. Segall, et al. · Journal of Allergy and Clinical Immunology · 14
Prevalence of Hepatitis Delta Virus (HDV) Infection in the United States: Results from an ICD-10 Review
2017 · Eduardo B. Martins, Jeffrey Glenn · Gastroenterology · 13
O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)
2015 · T. Berg, K.-G. Simon, et al. · Journal of Hepatology · 13
Works count: 79
Citation count: 2,382
H-index: 21
I10-index: 27
Year
Topic
Type